ID GLGB_FELCA Reviewed; 699 AA. AC Q6T308; DT 10-MAY-2005, integrated into UniProtKB/Swiss-Prot. DT 05-JUL-2004, sequence version 1. DT 27-MAR-2024, entry version 100. DE RecName: Full=1,4-alpha-glucan-branching enzyme; DE EC=2.4.1.18 {ECO:0000250|UniProtKB:Q04446}; DE AltName: Full=Brancher enzyme; DE AltName: Full=Glycogen-branching enzyme; GN Name=GBE1; OS Felis catus (Cat) (Felis silvestris catus). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Laurasiatheria; Carnivora; Feliformia; Felidae; Felinae; Felis. OX NCBI_TaxID=9685; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA], AND DISEASE. RA Fyfe J.C., Hawkins M.G., Henthorn P.S.; RT "Molecular characterization of feline glycogen storage disease type IV."; RL Submitted (OCT-2003) to the EMBL/GenBank/DDBJ databases. CC -!- FUNCTION: Required for normal glycogen accumulation. The alpha 1-6 CC branches of glycogen play an important role in increasing the CC solubility of the molecule. {ECO:0000250|UniProtKB:Q04446}. CC -!- CATALYTIC ACTIVITY: CC Reaction=Transfers a segment of a (1->4)-alpha-D-glucan chain to a CC primary hydroxy group in a similar glucan chain.; EC=2.4.1.18; CC Evidence={ECO:0000250|UniProtKB:Q04446}; CC -!- PATHWAY: Glycan biosynthesis; glycogen biosynthesis. CC {ECO:0000250|UniProtKB:Q04446}. CC -!- SUBUNIT: Monomer. {ECO:0000250|UniProtKB:Q04446}. CC -!- DOMAIN: Binds its carbohydrate substrate close to the active site, but CC also via regions close to the N-terminus; this may result in increased CC affinity and therefore increased catalytic efficiency. CC {ECO:0000250|UniProtKB:Q04446}. CC -!- DISEASE: Note=Defects in GBE1 are the cause of glycogen storage disease CC IV (GSD-IV). {ECO:0000269|Ref.1}. CC -!- SIMILARITY: Belongs to the glycosyl hydrolase 13 family. GlgB CC subfamily. {ECO:0000305}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; AY439007; AAR13899.1; -; mRNA. DR RefSeq; NP_001009872.1; NM_001009872.1. DR AlphaFoldDB; Q6T308; -. DR SMR; Q6T308; -. DR STRING; 9685.ENSFCAP00000049901; -. DR CAZy; CBM48; Carbohydrate-Binding Module Family 48. DR CAZy; GH13; Glycoside Hydrolase Family 13. DR PaxDb; 9685-ENSFCAP00000025102; -. DR GeneID; 493962; -. DR KEGG; fca:493962; -. DR eggNOG; KOG0470; Eukaryota. DR InParanoid; Q6T308; -. DR OrthoDB; 96at2759; -. DR UniPathway; UPA00164; -. DR Proteomes; UP000011712; Unplaced. DR GO; GO:0005737; C:cytoplasm; IBA:GO_Central. DR GO; GO:0003844; F:1,4-alpha-glucan branching enzyme activity; ISS:UniProtKB. DR GO; GO:0102752; F:1,4-alpha-glucan branching enzyme activity (using a glucosylated glycogenin as primer for glycogen synthesis); IEA:UniProtKB-EC. DR GO; GO:0043169; F:cation binding; IEA:InterPro. DR GO; GO:0004553; F:hydrolase activity, hydrolyzing O-glycosyl compounds; IEA:InterPro. DR GO; GO:0005978; P:glycogen biosynthetic process; ISS:UniProtKB. DR CDD; cd11321; AmyAc_bac_euk_BE; 1. DR CDD; cd02854; E_set_GBE_euk_N; 1. DR Gene3D; 3.20.20.80; Glycosidases; 1. DR Gene3D; 2.60.40.1180; Golgi alpha-mannosidase II; 1. DR Gene3D; 2.60.40.10; Immunoglobulins; 1. DR InterPro; IPR006048; A-amylase/branching_C. DR InterPro; IPR037439; Branching_enzy. DR InterPro; IPR006047; Glyco_hydro_13_cat_dom. DR InterPro; IPR004193; Glyco_hydro_13_N. DR InterPro; IPR013780; Glyco_hydro_b. DR InterPro; IPR017853; Glycoside_hydrolase_SF. DR InterPro; IPR013783; Ig-like_fold. DR InterPro; IPR014756; Ig_E-set. DR PANTHER; PTHR43651; 1,4-ALPHA-GLUCAN-BRANCHING ENZYME; 1. DR PANTHER; PTHR43651:SF3; 1,4-ALPHA-GLUCAN-BRANCHING ENZYME; 1. DR Pfam; PF00128; Alpha-amylase; 1. DR Pfam; PF02806; Alpha-amylase_C; 1. DR Pfam; PF02922; CBM_48; 1. DR PIRSF; PIRSF000463; GlgB; 1. DR SMART; SM00642; Aamy; 1. DR SUPFAM; SSF51445; (Trans)glycosidases; 1. DR SUPFAM; SSF81296; E set domains; 1. DR SUPFAM; SSF51011; Glycosyl hydrolase domain; 1. PE 2: Evidence at transcript level; KW Glycogen biosynthesis; Glycogen storage disease; Glycosyltransferase; KW Phosphoprotein; Reference proteome; Transferase. FT CHAIN 1..699 FT /note="1,4-alpha-glucan-branching enzyme" FT /id="PRO_0000188773" FT ACT_SITE 354 FT /note="Nucleophile" FT /evidence="ECO:0000250" FT ACT_SITE 409 FT /note="Proton donor" FT /evidence="ECO:0000250" FT BINDING 59..60 FT /ligand="substrate" FT /evidence="ECO:0000250|UniProtKB:Q04446" FT BINDING 88..90 FT /ligand="substrate" FT /evidence="ECO:0000250|UniProtKB:Q04446" FT BINDING 115..118 FT /ligand="substrate" FT /evidence="ECO:0000250|UniProtKB:Q04446" FT BINDING 330..333 FT /ligand="substrate" FT /evidence="ECO:0000250|UniProtKB:Q04446" FT MOD_RES 170 FT /note="Phosphotyrosine" FT /evidence="ECO:0000250|UniProtKB:Q04446" SQ SEQUENCE 699 AA; 80564 MW; 2B463AA38C5CCEA3 CRC64; MAAPVARGEC SEAALAAALA DVPELARLLE LDPYLKPFAL DFQRRYKKFN ETLNNIGENE GGIDKFSRGY ESFGVHRCAD GGLYCKEWAP GAEGVFLTGD FNDWNPFSYP YKKLDYGKWE LYIPPKQNKS QLVPHGSKLK VVIRSKSGEI LYRISPWAKY VTREGENVNY DWTHWDPEHP YKFKHSRPKK PRGVRIYESH VGISSYEGKI ASYKHFTYNV LPRIKDLGYN CIQMMAIMEH AYYASFGYQI TSFFAASSRY GTPEELKELV DTAHSMGITV LLDVVHSHAS KNSEDGLNMF DGTDSCYFHS GPRGNHDLWD SRLFIYSSWE VLRFLLSNIR WWLEEYGFDG FRFDGVTSML YHHHGMGQAF SGDYHEYFGL QVDEDALIYL MLANHLVHTL YPNSITIAED VSGMPALCSP ISQGGVGFDY RLAMAIPDKW IQLLKEFKDE DWNMGNIVYT LTNRRYLEKC IAYAESHDQA LVGDKTLAFW LMDAEMYTNM SVLTPFTPVI DRGIQLHKMI RLITHALGGE GYLNFMGNEF GHPEWLDFPR KGNNESYHYA RRQFHLTDDD LLRYKFLNNF DRDMNKLEER CGWLSAPQAF VSEKHEGNKI IAFERAGLVF IFNFHPSKSY TDYRVGTTLP GKFRIVLDTD AAEYGGHQRL DHSTEFFSQP FKHNERPCSL LVYIPNRVGL ILQNVDMPN //